AILYNIX

We are a Artificial Intelligence (AI) Drug Design and Discovery Research and Development company, applying Deep Learning (DL) and Convolutional Graph Networks (CGNs) with , which utilize either supervised training procedures that is the foundation of its proprietary Computational Drug Design and Discovery Platforms, which in turn creates multiple AI-Enabled Biotech startups and collaborating with Academia and Contract Research Organizations (CRO) end-to-end integration that aims to improve the linking of data elements, to enhance the linkages among all stakeholders in drug research, development, commercialization, and delivery.

Primary location: Santa Clara United States